These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 30257956)

  • 1. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
    Taur Y; Coyte K; Schluter J; Robilotti E; Figueroa C; Gjonbalaj M; Littmann ER; Ling L; Miller L; Gyaltshen Y; Fontana E; Morjaria S; Gyurkocza B; Perales MA; Castro-Malaspina H; Tamari R; Ponce D; Koehne G; Barker J; Jakubowski A; Papadopoulos E; Dahi P; Sauter C; Shaffer B; Young JW; Peled J; Meagher RC; Jenq RR; van den Brink MRM; Giralt SA; Pamer EG; Xavier JB
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
    Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
    Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota in transplant patients.
    Chong PP; Koh AY
    Blood Rev; 2020 Jan; 39():100614. PubMed ID: 31492463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation.
    Henig I; Yehudai-Ofir D; Zuckerman T
    Haematologica; 2021 Apr; 106(4):933-946. PubMed ID: 33241674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
    Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
    Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
    Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
    Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
    Shono Y; van den Brink MRM
    Nat Rev Cancer; 2018 May; 18(5):283-295. PubMed ID: 29449660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Taur Y; Xavier JB; Lipuma L; Ubeda C; Goldberg J; Gobourne A; Lee YJ; Dubin KA; Socci ND; Viale A; Perales MA; Jenq RR; van den Brink MR; Pamer EG
    Clin Infect Dis; 2012 Oct; 55(7):905-14. PubMed ID: 22718773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation.
    Doki N; Suyama M; Sasajima S; Ota J; Igarashi A; Mimura I; Morita H; Fujioka Y; Sugiyama D; Nishikawa H; Shimazu Y; Suda W; Takeshita K; Atarashi K; Hattori M; Sato E; Watakabe-Inamoto K; Yoshioka K; Najima Y; Kobayashi T; Kakihana K; Takahashi N; Sakamaki H; Honda K; Ohashi K
    Ann Hematol; 2017 Sep; 96(9):1517-1523. PubMed ID: 28733895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal microbiota transplantation to prevent complications after allogeneic stem cell transplantation for haematological malignancies: a study protocol for a randomised controlled phase-II trial (the FMT-allo study).
    Dougé A; Ravinet A; Corriger A; Cabrespine A; Wasiak M; Pereira B; Sokol H; Nguyen S; Bay JO
    BMJ Open; 2023 May; 13(5):e068480. PubMed ID: 37130682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
    DeFilipp Z; Hohmann E; Jenq RR; Chen YB
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
    Ingham AC; Kielsen K; Mordhorst H; Ifversen M; Aarestrup FM; Müller KG; Pamp SJ
    Microbiome; 2021 Jun; 9(1):148. PubMed ID: 34183060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review.
    Pession A; Zama D; Muratore E; Leardini D; Gori D; Guaraldi F; Prete A; Turroni S; Brigidi P; Masetti R
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33557125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation.
    Yu J; Sun H; Cao W; Han L; Song Y; Wan D; Jiang Z
    Exp Hematol Oncol; 2020 Dec; 9(1):35. PubMed ID: 33292670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
    Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
    Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.